204 related articles for article (PubMed ID: 447856)
1. Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis.
Goldblum SE; Van Epps DE; Reed WP
J Clin Invest; 1979 Jul; 64(1):255-64. PubMed ID: 447856
[TBL] [Abstract][Full Text] [Related]
2. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
Perez HD; Lipton M; Goldstein IM
J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
[TBL] [Abstract][Full Text] [Related]
3. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
Clark RA; Klebanoff SJ
J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
[TBL] [Abstract][Full Text] [Related]
4. Complement (C5)-derived chemotactic activity in serum from patients with pancreatitis.
Perez HD; Horn JK; Ong R; Goldstein IM
J Lab Clin Med; 1983 Jan; 101(1):123-9. PubMed ID: 6848611
[TBL] [Abstract][Full Text] [Related]
5. Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
Hill HR; Bohnsack JF; Morris EZ; Augustine NH; Parker CJ; Cleary PP; Wu JT
J Immunol; 1988 Nov; 141(10):3551-6. PubMed ID: 3053900
[TBL] [Abstract][Full Text] [Related]
6. Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis.
Rhodes JM; Potter BJ; Brown DJ; Jewell DP
Gastroenterology; 1982 Jun; 82(6):1327-34. PubMed ID: 6978274
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect on rabbit peritoneal leukocyte and macrophage chemotaxis by sera from patients with pulmonary sarcoidosis: significance of serum chemotactic inhibitor in sarcoidosis].
Okuyama Y
Hokkaido Igaku Zasshi; 1982 Mar; 57(2):197-209. PubMed ID: 7118051
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibitor of complement (C5)-derived chemotactic activity in systemic lupus erythematosus related antigenically to the Bb fragment of human factor B.
Perez HD; Hooper C; Volanakis J; Ueda A
J Immunol; 1987 Jul; 139(2):484-9. PubMed ID: 3648093
[TBL] [Abstract][Full Text] [Related]
9. Polymorphonuclear leukocyte and monocyte chemoattractants produced by human fibroblasts.
Sobel JD; Gallin JI
J Clin Invest; 1979 Apr; 63(4):609-18. PubMed ID: 438325
[TBL] [Abstract][Full Text] [Related]
10. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities.
Matsubara S; Yamamoto T; Tsuruta T; Takagi K; Kambara T
Am J Pathol; 1991 May; 138(5):1279-91. PubMed ID: 2024711
[TBL] [Abstract][Full Text] [Related]
11. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
[TBL] [Abstract][Full Text] [Related]
12. Hereditary deficiency of the fifth component of complement in man. II. Biological properties of C5-deficient human serum.
Rosenfeld SI; Baum J; Steigbigel RT; Leddy JP
J Clin Invest; 1976 Jun; 57(6):1635-43. PubMed ID: 777027
[TBL] [Abstract][Full Text] [Related]
13. The effect of hemodialysis on neutrophil chemotactic responsiveness.
Greene WH; Ray C; Mauer SM; Quie PG
J Lab Clin Med; 1976 Dec; 88(6):971-4. PubMed ID: 993648
[TBL] [Abstract][Full Text] [Related]
14. Antigenic identification of chemotactic factor inactivator in normal human serum and bronchoalveolar lavage fluid.
Robbins RA; Rasmussen JK; Clayton ME; Gossman GL; Kendall TJ; Rennard SI
J Lab Clin Med; 1987 Sep; 110(3):292-9. PubMed ID: 3611952
[TBL] [Abstract][Full Text] [Related]
15. Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.
Kazmierowski JA; Gallin JI; Reynolds HY
J Clin Invest; 1977 Feb; 59(2):273-81. PubMed ID: 401834
[TBL] [Abstract][Full Text] [Related]
16. Polymorphonuclear leukocyte chemotaxis in systemic lupus erythematosus.
Perez HD; Goldstein IM
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():53-8. PubMed ID: 3612652
[TBL] [Abstract][Full Text] [Related]
17. Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.
Orr FW; Varani J; Kreutzer DL; Senior RM; Ward PA
Am J Pathol; 1979 Jan; 94(1):75-83. PubMed ID: 569981
[TBL] [Abstract][Full Text] [Related]
18. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis.
Matzner Y; Marx G; Drexler R; Eldor A
Thromb Haemost; 1984 Oct; 52(2):134-7. PubMed ID: 6084320
[TBL] [Abstract][Full Text] [Related]
20. Role of chemotactic factor inactivation in neutrophil chemotaxis.
Tannous R; Cavender-Zylich N; Ginsberg BH
J Lab Clin Med; 1981 Aug; 98(2):238-50. PubMed ID: 7252332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]